{
  "id": "preventing-cardiovascular-disease-needs-better-risk-prediction",
  "title": "Preventing cardiovascular disease needs better risk prediction",
  "summary": "Corsera COO explains why the biotech is building an AI-powered risk assessment tool alongside RNAi therapies targeting CVD. Earlier this month, US biotech Corsera Health announced an $80 million Series A raise, fueling its ambitious two-pronged strategy to push cardiovascular care towards a preventive model. The Boston-based company aims to pair long-acting preventive RNA interference [â€¦] The post Preventing cardiovascular disease needs better risk prediction appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/preventing-cardiovascular-disease-needs-better-risk-prediction/",
  "source": "Longevity.Technology",
  "author": "Danny Sullivan",
  "category": "news",
  "publishedAt": "2026-01-30T17:26:13.000Z",
  "fetchedAt": "2026-02-04T10:49:05.818Z",
  "relevanceScore": 0.5,
  "matchedKeywords": [
    "longevity",
    "cardiovascular"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.862Z"
}